In addition, TRAF4 activated the PI3K/AKT signaling pathway to promote the migration and invasion of hepatocellular carcinoma cells [26], and clinical evidence suggested that TRAF4 was closely associated with poor prognosis in intrahepatic cholangiocarcinoma [27]. This evidence concerns the gene TRAF4 and hepatocellular carcinoma.